Collective Molecular Activities of the Plant: Withania Somnifera
Example Image
PLANiTS DNA barcode
Taxonomic Information
Plant ID: NPO15698
Plant Latin Name: Withania Somnifera
Taxonomy Genus: Withania
Taxonomy Family: Solanaceae
Plant External Links:
NCBI TaxonomyDB:
126910
Plant-of-the-World-Online:
n.a.
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Compounds Summary
Overview of Ingredients
46 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
24 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
18 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC91034
Ingredient ID: NPC66052
Ingredient ID: NPC63735
Ingredient ID: NPC58966
Ingredient ID: NPC486571
Ingredient ID: NPC486570
Ingredient ID: NPC486569
Ingredient ID: NPC486568
Ingredient ID: NPC486567
Ingredient ID: NPC486566
Ingredient ID: NPC486565
Ingredient ID: NPC42619
Ingredient ID: NPC38427
Ingredient ID: NPC311088
Ingredient ID: NPC286528
Ingredient ID: NPC284915
Ingredient ID: NPC282585
Ingredient ID: NPC280664
Ingredient ID: NPC276434
Ingredient ID: NPC265645
Ingredient ID: NPC264858
Ingredient ID: NPC261345
Ingredient ID: NPC260623
Ingredient ID: NPC259771
Ingredient ID: NPC253038
Ingredient ID: NPC250312
Ingredient ID: NPC23900
Ingredient ID: NPC235580
Ingredient ID: NPC219864
Ingredient ID: NPC205553
Ingredient ID: NPC186343
Ingredient ID: NPC185776
Ingredient ID: NPC185498
Ingredient ID: NPC183943
Ingredient ID: NPC179634
Ingredient ID: NPC174042
Ingredient ID: NPC170538
Ingredient ID: NPC167606
Ingredient ID: NPC16461
Ingredient ID: NPC154491
Ingredient ID: NPC1535
Ingredient ID: NPC145382
Ingredient ID: NPC138112
Ingredient ID: NPC127074
Ingredient ID: NPC120994
Ingredient ID: NPC106526
Classification of Human Proteins Collectively Targeted by the Plant
*The classification criteria of Drug Transporter (DTP), CYP450 are referred to DrugMap. Other molecular targets in CMAUP are classified as therapeutic targets.
.
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Therapeutic Target | Histone acetyltransferase | NCOA3 | Nuclear receptor coactivator 3 | Q9Y6Q9 | CHEMBL1615382 |
| Therapeutic Target | Isomerase | TOP2B | DNA topoisomerase II beta | Q02880 | CHEMBL3396 |
Clinical Trials Summary
Overview
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 987 | |
 Plant level | 11 | |
Clinical trial details
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT04638790 | First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00109928 | S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00500890 | Treatment of Tumors of the Choroid Plexus Epithelium | choroid plexus neoplasm | Etoposide (NPC185498) | NP level |
| NCT02039726 | (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03383406 | A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01331590 | Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01859741 | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02306291 | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03117751 | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00134030 | Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00691210 | Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies | Hodgkins lymphoma;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00554463 | G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03780621 | Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment | Cognitive Impairment;Mild | Withania Somnifera | Plant level As plant Extract |
| NCT03747679 | Palatability (Taste) of Oral Formulations of Bosutinib | chronic myelogenous leukemia | Sorbitol (NPC66052) | NP level |
| NCT00025324 | Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00616785 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03860844 | Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00926640 | A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00334867 | Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00653068 | Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002565 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02653196 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | neuroepithelial neoplasm | Etoposide (NPC185498) | NP level |
| NCT00003113 | Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005631 | Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01906814 | Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00004110 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00042835 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | lung adenocarcinoma;squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002768 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002757 | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00274950 | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | childhood germ cell tumor;ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00179920 | Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00002517 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT02194049 | Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00244946 | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00388349 | Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00537511 | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00058292 | Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01032070 | Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma | childhood ependymoma | Etoposide (NPC185498) | NP level |
| NCT01076231 | Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00054665 | PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05270057 | Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies | Burkitts lymphoma | Etoposide (NPC185498) | NP level |
| NCT00098774 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03023046 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002936 | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | lymphoma;sarcoma | Etoposide (NPC185498) | NP level |
| NCT00427791 | Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00041015 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03018626 | R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003190 | Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia with maturation;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia | Etoposide (NPC185498) | NP level |
| NCT04254471 | This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04917250 | GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00776802 | GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006487 | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00233987 | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01013779 | Merkel Positron Emission Tomography (PET) Protocol | Merkel cell skin cancer | Etoposide (NPC185498) | NP level |
| NCT01900509 | Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies | Hodgkins lymphoma;leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00720109 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00002865 | High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002868 | Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00079040 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003996 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002719 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04740021 | Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00810017 | Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00006032 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT04622228 | Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00080886 | Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01947062 | Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00006669 | Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02298283 | Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT04028050 | A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02947113 | Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00529503 | A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00045617 | S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00083551 | UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01178658 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006734 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00002905 | Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01165112 | Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma | diffuse large B-cell lymphoma;Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002461 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02199184 | Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia | AIDS;acute lymphoblastic leukemia;Burkitts lymphoma | Etoposide (NPC185498) | NP level |
| NCT03041311 | Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00012051 | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00135135 | Therapy for Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02631239 | MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01563601 | Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02848183 | Optimal Treatment Strategy Based on for Pediatric AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01104025 | Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00058461 | Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | Burkitts lymphoma;diffuse large B-cell lymphoma;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT01025778 | Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00627354 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT04696575 | Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002822 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00118209 | Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00871013 | Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00276809 | Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Etoposide (NPC185498) | NP level |
| NCT00004006 | Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00002945 | High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00006040 | Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
| NCT02934503 | Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00187083 | A Study of Children With Refractory or Relapsed ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01294670 | Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors | sarcoma | Etoposide (NPC185498) | NP level |
| NCT03382561 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00209222 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00776698 | A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01840566 | High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00372593 | Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00310128 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT05430685 | The Impact of Ashwagandha on Perceived Stress;Sleep and Food Cravings in College Students | Stress|Sleep|Craving|Well Being | Withania Somnifera | Plant level As single plant |
| NCT03135977 | Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03991884 | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT04778410 | Study of Magrolimab Combinations in Participants With Myeloid Malignancies | cancer | Etoposide (NPC185498) | NP level |
| NCT00003052 | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02366663 | BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00712582 | Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT05006664 | Brentuximab Vedotin in Combination With CHEP in Patient With PTCL | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03623087 | SIMPLE Chemotherapy for NK Lymphoma/Leukaemia | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00146120 | Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00014313 | Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00666484 | Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006455 | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02763579 | A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00906945 | Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT05092412 | Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03628131 | Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00278252 | Etoposide in Treating Young Patients With Relapsed Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT02987998 | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04996771 | Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002531 | Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03663166 | Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01914718 | Dose-adjusted EPOCH-R in MYC Positive DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00482053 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002756 | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00742924 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT01528969 | Effect of Xylitol on Oral Microbiota in Children | bacterial disease | Sorbitol (NPC66052) | NP level |
| NCT00008190 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04221035 | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04154189 | A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT01959698 | Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01710176 | Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
| NCT01548573 | Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00591630 | Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003397 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005985 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03850067 | A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002974 | Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00186966 | Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02421939 | A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00387699 | Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00003309 | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00053352 | Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | Ovarian Embryonal Carcinoma;Ovarian Yolk Sac Tumor;teratoma;Testicular Choriocarcinoma;Testicular Yolk Sac Tumor | Etoposide (NPC185498) | NP level |
| NCT04696939 | Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002532 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03182244 | A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00137995 | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00939653 | T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00791947 | A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00278278 | Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03467360 | Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00021112 | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00124644 | Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02940990 | SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01092182 | Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma | Burkitts lymphoma;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003815 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00275015 | Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Etoposide (NPC185498) | NP level |
| NCT00002827 | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02359162 | Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005578 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02116959 | Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00017225 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003631 | Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02243436 | Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00567567 | Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00231582 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT00005613 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02748889 | Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00264953 | HD11 for Intermediate Stages | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00011921 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03769935 | Maintenance Therapy for Small-cell Lung Cancer | colorectal cancer | Etoposide (NPC185498) | NP level |
| NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04665856 | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01237678 | A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002549 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002887 | Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002714 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01573338 | Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00618501 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02157792 | M6620 First in Human Study | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00083538 | Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00660036 | Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00350181 | Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT | acute graft vs. host disease;leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03736616 | Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03793478 | Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02836639 | BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00977561 | A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02631109 | L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00002704 | Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00003436 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00374881 | A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects | pain | Sorbitol (NPC66052) | NP level |
| NCT04501718 | Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT03937843 | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma | seminoma;testicular carcinoma | Etoposide (NPC185498) | NP level |
| NCT02338518 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients | gastric cancer | Etoposide (NPC185498) | NP level |
| NCT04005716 | Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003696 | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04330326 | Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease | non-alcoholic fatty liver disease | Sorbitol (NPC66052) | NP level |
| NCT00003859 | Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00003727 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00265031 | HD12 for Advanced Stages | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04363255 | First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02499770 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00569985 | Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00924209 | A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00352027 | Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00094497 | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003941 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | mediastinal cancer;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT00066222 | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00052923 | Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00000660 | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | Kaposi's sarcoma | Etoposide (NPC185498) | NP level |
| NCT00410423 | Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias | leukemia | Etoposide (NPC185498) | NP level |
| NCT03794167 | BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00379457 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT01117441 | International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02639650 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | gestational trophoblastic neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002766 | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT01979536 | Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01722292 | A Study of LY2940680 in Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00131027 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03535961 | Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00562978 | Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00242996 | Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00026208 | Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02949258 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | gastric cancer | Etoposide (NPC185498) | NP level |
| NCT00577993 | Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005977 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00240097 | Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02063022 | Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma | Ewing sarcoma | Etoposide (NPC185498) | NP level |
| NCT00426101 | Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00004169 | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03643276 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00539500 | Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03064867 | Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00335738 | Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00003783 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00430118 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00086944 | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002829 | Bone Marrow Transplantation in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04203511 | INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00145002 | A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) | adult T-cell leukemia/lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002715 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02166463 | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003812 | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00003625 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00417248 | Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02262325 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04923776 | Liver Directed RT + Chemo-immunotherapy for ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00612430 | Ph II Bevacizumab + Etoposide for Pts w Recurrent MG | gliosarcoma | Etoposide (NPC185498) | NP level |
| NCT00083161 | Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04077905 | Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT03596307 | The Effects of Ashwagandha in Endurance Exercise Performance | Healthy | Withania Somnifera | Plant level As single plant |
| NCT00005780 | Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01492556 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00880243 | Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01920932 | Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04012606 | Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00040690 | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003262 | Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection | lymphoma | Etoposide (NPC185498) | NP level |
| NCT05116007 | Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02518750 | Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT04139304 | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00881166 | Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT02471911 | KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT05309629 | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT04422210 | A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00315705 | A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01063439 | BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02179528 | Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002642 | SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00004186 | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00022737 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | childhood acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT05403723 | Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03321890 | Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00365755 | Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00002987 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003573 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00060385 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00514540 | Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT03188198 | Risk Adapted Therapy in Diffuse Large B Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00398554 | Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002610 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT04063163 | A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00303849 | Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | anaplastic oligodendroglioma | Etoposide (NPC185498) | NP level |
| NCT01579929 | Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | lung cancer | Etoposide (NPC185498) | NP level |
| NCT05294055 | Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT04189094 | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002816 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03213977 | R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00024193 | Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04380636 | Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00023998 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00002657 | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00061919 | Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00801918 | Denileukine Diftitox for Relapsed ALCL | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01589159 | A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes | breast cancer | Etoposide (NPC185498) | NP level |
| NCT03980925 | Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. | digestive system neuroendocrine neoplasm | Etoposide (NPC185498) | NP level |
| NCT00250718 | Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00018954 | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT02911142 | Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | B-cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT05338541 | Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood. | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00576979 | Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00613626 | Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04699838 | Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00379340 | Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | Wilms tumor | Etoposide (NPC185498) | NP level |
| NCT00002521 | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03568994 | Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03811002 | Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00025402 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00695409 | Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03043872 | Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05001412 | Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003053 | Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03669783 | Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm) | childhood kidney neoplasm | Etoposide (NPC185498) | NP level |
| NCT05008224 | Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | carcinoma | Etoposide (NPC185498) | NP level |
| NCT03636971 | Gait Analysis Following Knee Viscosupplementation | osteoarthritis | Sorbitol (NPC66052) | NP level |
| NCT00262210 | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02228512 | Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | Castleman disease;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00209833 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | refractory anemia | Etoposide (NPC185498) | NP level |
| NCT02329080 | New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00070200 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003632 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03926624 | Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00004054 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003119 | Surgery in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01987232 | Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02582697 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT00265889 | Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01476839 | Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03077828 | Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00070187 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00033696 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00025636 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00274807 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00020943 | Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00416832 | Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03504410 | Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00005823 | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
| NCT00216125 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04833114 | Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002876 | Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00025428 | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02408042 | Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) | Hodgkins lymphoma;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004188 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00002588 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01064466 | Pharmacogenomics IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00304018 | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer | leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT02323737 | Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02412267 | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006374 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00005946 | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation | leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT04560972 | LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00577629 | Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00351195 | Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002805 | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia | Etoposide (NPC185498) | NP level |
| NCT00702962 | Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03742115 | Etoposide in the First-line Treatment of Adult EBV-HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00274924 | Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02899728 | Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01474499 | A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation | Constipation | Sorbitol (NPC66052) | NP level |
| NCT02070458 | Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT01251107 | Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03349346 | Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT05224141 | Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01371981 | Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | myeloid sarcoma | Etoposide (NPC185498) | NP level |
| NCT04573153 | Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients | COVID-19 | Sorbitol (NPC66052) | NP level |
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00032019 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00052299 | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002701 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04951115 | A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00069238 | Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00476190 | ALL Adult Consortium Trial: Adult ALL Trial | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03531281 | Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT02773732 | Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02875457 | Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00504751 | Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00276731 | Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT05364424 | A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT05354700 | A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00807755 | Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00336024 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma | medulloblastoma;primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
| NCT01681537 | Lenalidomide Plus Chemotherapy for AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03389087 | Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00761761 | Sensoril(Ashwaganhda)for Bipolar Disorder | Bipolar I Disorder|Bipolar II Disorder|Bipolar Disorder NOS | Withania Somnifera | Plant level As single plant |
| NCT00556127 | Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006012 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00499616 | Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02636322 | Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00072384 | Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT01055314 | Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma | alveolar rhabdomyosarcoma;embryonal rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT00002785 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002481 | Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00878254 | Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00049036 | Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT02595424 | Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery | pancreatic endocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003816 | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer | chronic myeloproliferative disorder;leukemia;lymphoma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00006373 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02632708 | Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02867956 | Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT02815592 | Trial of BMS-986012 in Combination With Platinum and Etoposide | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02870907 | Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT01027923 | IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00039195 | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004900 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT04346914 | Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00025272 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00521014 | GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01793935 | Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia | Schizophrenia|Schizoaffective Disorder | Withania Somnifera | Plant level As plant Extract |
| NCT00009815 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT02523976 | Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | lymphoid leukemia | Etoposide (NPC185498) | NP level |
| NCT00003194 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00798148 | 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03517137 | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003935 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002611 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT00041210 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00869752 | MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04452370 | Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00002550 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002494 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003597 | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT00002510 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00481832 | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00098839 | Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) | childhood acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01435018 | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS | HIV-1 infection | Etoposide (NPC185498) | NP level |
| NCT00003243 | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | myelodysplastic/myeloproliferative disease;leukemia;lymphoma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT02592876 | Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003158 | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002675 | Chemotherapy in Treating Patients With Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00255723 | Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004010 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00100477 | Use of Topotecan in Patients With Refractory Acute Leukemia | leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT04472949 | Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00967369 | Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005090 | S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002788 | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01180322 | Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03061656 | Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00186888 | Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00084838 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT02553460 | Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT02101853 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00809341 | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00079105 | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002836 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00003364 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00005793 | A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | leukemia | Etoposide (NPC185498) | NP level |
| NCT05484583 | Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05298423 | Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00774046 | High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00613457 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00003602 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00151255 | All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02794571 | Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT04326439 | AflacLL1901 (CHOA-AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00682981 | A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT04989283 | Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00621361 | Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00180908 | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00003401 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00288626 | High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study | relapsing-remitting multiple sclerosis | Etoposide (NPC185498) | NP level |
| NCT00204646 | Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | sarcoma | Etoposide (NPC185498) | NP level |
| NCT02722369 | STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03567642 | A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02896582 | Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03553238 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT04543890 | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01222572 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03432598 | Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00004906 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00568464 | Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) | Ewing sarcoma | Etoposide (NPC185498) | NP level |
| NCT00085098 | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT02605421 | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04774380 | Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00032149 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00388960 | Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02776605 | Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT02912702 | L-DEP as an Initial Treatment for EBV-HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00878449 | A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00324467 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | neoplasm of mature B-cells;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01775475 | Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT00559104 | Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03367143 | Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04092283 | Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01055301 | S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT05245994 | An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003399 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03755804 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02768558 | Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03100955 | A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer | colorectal cancer | Etoposide (NPC185498) | NP level |
| NCT05353257 | A Study to Evaluate the Efficacy and Safety of HLX10 in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002798 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;chronic myelomonocytic leukemia;refractory anemia;refractory anemia with excess blasts | Etoposide (NPC185498) | NP level |
| NCT00392886 | Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT02400281 | Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01653418 | Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT03019640 | Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00070174 | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | leukemia | Etoposide (NPC185498) | NP level |
| NCT00660504 | Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00072280 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00005834 | S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00006695 | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00042978 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00632853 | Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00534469 | Auto BMT for Non-M3 AML in 1st Remission in Pts | leukemia | Etoposide (NPC185498) | NP level |
| NCT02631252 | Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00002471 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00049218 | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00186875 | Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03273829 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | leukemia | Etoposide (NPC185498) | NP level |
| NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
| NCT03699956 | RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04684017 | Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00079482 | Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01226849 | Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00041327 | Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT05091567 | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00006260 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00703820 | Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04061772 | A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05142865 | Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00970385 | Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02289690 | Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05026593 | A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00574080 | UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT04762758 | Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients | Charcot-Marie-Tooth disease | Sorbitol (NPC66052) | NP level |
| NCT00004086 | Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT01949129 | Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01258634 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT04624204 | Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00193596 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site | neoplasm | Etoposide (NPC185498) | NP level |
| NCT02570542 | Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005863 | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
| NCT04681417 | Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT02176967 | Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02372409 | Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors | anaplastic astrocytoma;glioblastoma multiforme;oligoastrocytoma;oligodendroglioma;optic nerve glioblastoma;pilocytic astrocytoma | Etoposide (NPC185498) | NP level |
| NCT00002912 | Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00472056 | Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02349178 | Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02341989 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | seminoma;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT00791154 | QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00077285 | Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00003606 | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03786783 | Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03385096 | Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00225173 | Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00304070 | Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
| NCT02405676 | BNHL-2015 for Children or Adolescents in China | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT00002567 | High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission | leukemia | Etoposide (NPC185498) | NP level |
| NCT00887159 | A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00025363 | Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT00017368 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03613597 | Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00416676 | Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00049439 | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003423 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01873326 | Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT01411098 | Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00002961 | Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00004907 | Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002590 | Combination Chemotherapy in Treating Children With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005978 | N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT03840902 | M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002638 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02771743 | Response-based Treatment of High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00083681 | DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00499343 | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00193505 | Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00061893 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | sarcoma | Etoposide (NPC185498) | NP level |
| NCT04256421 | A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00470223 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT03004287 | 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01329900 | Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01899066 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00554788 | Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT01030900 | Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas | diffuse large B-cell lymphoma;Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002634 | Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00041054 | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT05389423 | Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas | Burkitts lymphoma;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04585893 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | Castleman disease | Etoposide (NPC185498) | NP level |
| NCT03418038 | Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or Clonal Cytopenia of Undetermined Significance | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00916669 | A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00920153 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00114738 | EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02512926 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | leukemia | Etoposide (NPC185498) | NP level |
| NCT01565772 | Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00027846 | Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00162695 | Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT01097057 | Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003114 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT05221645 | Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00137111 | Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00006461 | Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor | medulloblastoma;primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
| NCT01468740 | Prospective Study on HIV-related Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002516 | Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT04878016 | A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00734877 | UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00400946 | Treatment of Acute Lymphoblastic Leukemia in Children | leukemia | Etoposide (NPC185498) | NP level |
| NCT00822120 | S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02883049 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00007865 | Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04177004 | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT00187005 | Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00572169 | UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT05458180 | CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04356690 | Etoposide in Patients With COVID-19 Infection | COVID-19 | Etoposide (NPC185498) | NP level |
| NCT02574728 | Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT00047138 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03407144 | Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02703272 | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00083915 | DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02845882 | LBL-2016 for Children or Adolescents in China | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00667615 | Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003860 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00110110 | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT05192889 | Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT05384015 | Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02402920 | Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02018861 | A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) | cancer | Etoposide (NPC185498) | NP level |
| NCT03901118 | Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT05466318 | ChiCGB vs BEAM in High-risk or R/R Lymphomas | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01178645 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT05453500 | Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT04683198 | Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01756989 | ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors | glioma | Etoposide (NPC185498) | NP level |
| NCT02626338 | Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00349778 | High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02937116 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT04730999 | Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00401609 | G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002596 | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors | childhood germ cell tumor;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT03617432 | Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients | neoplasm | Etoposide (NPC185498) | NP level |
| NCT02661503 | HD21 for Advanced Stages | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT03072771 | Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03591510 | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01356290 | Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT01746173 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | T-cell non-Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003141 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | brain neoplasm;neuroblastoma;sarcoma | Etoposide (NPC185498) | NP level |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003728 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT04765098 | Tamoxifen Versus Etoposide After First Recurrence in GBM Patients | glioblastoma multiforme | Etoposide (NPC185498) | NP level |
| NCT00002557 | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04675697 | Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05422183 | Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03116971 | Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00958022 | Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02429700 | TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | ovarian sex cord-stromal tumor | Etoposide (NPC185498) | NP level |
| NCT01154439 | Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00003380 | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | fallopian tube cancer;peritoneum cancer;ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00589056 | Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02356159 | Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation | Hodgkins lymphoma;leukemia;multiple myeloma;myelodysplastic syndrome;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00025649 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00869232 | UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02825147 | Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00202800 | Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Etoposide (NPC185498) | NP level |
| NCT01134861 | Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04490421 | Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03583710 | Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
| NCT02219737 | Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02861573 | Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT05142696 | A Safety Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) Patients in Combination With Carboplatin, Etoposide and Tislelizumab | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00458848 | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03570983 | A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00151242 | Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00002926 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT03206671 | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT03328104 | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | lymphoid leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT04712903 | Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05348213 | Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00984997 | Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02538926 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | T-lymphoblastic lymphoma;T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00732498 | Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02964013 | Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00571493 | VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03519971 | Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00005867 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03059667 | Immunotherapy as Second-line in Patient With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00354744 | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT02025881 | Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00983944 | Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04322318 | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | kidney Wilms tumor | Etoposide (NPC185498) | NP level |
| NCT01300793 | Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide | neoplasm of mature B-cells;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00367497 | Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00568607 | Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01783535 | Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | chronic lymphocytic leukemia;diffuse large B-cell lymphoma;Hodgkins lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004898 | Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT01169636 | Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00439556 | Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002674 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04728230 | Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00985855 | Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02337712 | Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00003389 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00217503 | Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00144989 | A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02443077 | Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT00320359 | Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05058651 | Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung | small cell carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003578 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01857453 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00062439 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002522 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004224 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00072527 | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT05361395 | First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma | Osteosarcoma | Withania Somnifera | Plant level As plant Extract |
| NCT00005802 | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00006363 | Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | acute basophilic leukemia;acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT03923179 | Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00109031 | Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) | leukemia;lymphoma;cancer | Etoposide (NPC185498) | NP level |
| NCT01511562 | Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01604863 | A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies | cancer | Etoposide (NPC185498) | NP level |
| NCT01451515 | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00882076 | Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias | leukemia | Etoposide (NPC185498) | NP level |
| NCT01411267 | AC220 for Children With Relapsed/Refractory ALL or AML | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01822496 | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03723941 | Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003299 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00045162 | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01059071 | Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Etoposide (NPC185498) | NP level |
| NCT00936936 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | testicular carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002658 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00598169 | Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01857934 | Therapy for Children With Advanced Stage Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00002697 | Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00549848 | Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00020709 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung adenocarcinoma;squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01569204 | Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01830777 | Brentuximab Vedotin + Re-induction Chemotherapy for AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01555541 | Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00439361 | Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02502708 | Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors | gliosarcoma;ependymoma;medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00536978 | Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT03586999 | Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03533972 | Effect of Ashwagandha on Salivary Antioxidant and Serum c Reactive Protein in Chronic Generalized Periodontitis | Chronic Periodontitis | Withania Somnifera | Plant level As single plant |
| NCT00017251 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04981899 | A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03711305 | Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05450458 | Hyaluronic Acid in Overuse Knee Pain | injury | Sorbitol (NPC66052) | NP level |
| NCT04702880 | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01525927 | Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity | neoplasm of oropharynx | Etoposide (NPC185498) | NP level |
| NCT03700359 | A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002800 | Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | neutropenia;leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT01356680 | HD17 for Intermediate Stage Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006122 | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01729845 | Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT05468489 | To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00025103 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT00693719 | Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00641381 | Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01415765 | MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00053768 | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00808899 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02371161 | Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002688 | Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01000285 | EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma | T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00578864 | Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00040872 | Multiple Therapies in Treating Patients With Advanced Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | Burkitts lymphoma | Etoposide (NPC185498) | NP level |
| NCT04469530 | Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00933673 | New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00030719 | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00057811 | Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma | anaplastic large cell lymphoma;Burkitts lymphoma;childhood acute lymphoblastic leukemia;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00025064 | Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04520074 | Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT04924101 | Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00004176 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04551131 | Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00793845 | Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00193531 | Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT01014767 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | brain cancer;choroid plexus neoplasm | Etoposide (NPC185498) | NP level |
| NCT00195871 | Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00073918 | Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;MALT lymphoma;Waldenstrom macroglobulinemia;Burkitts lymphoma;diffuse large B-cell lymphoma;follicular lymphoma;lymphoblastic lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04871607 | Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03161054 | Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00016887 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00027898 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT02638428 | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT05367856 | Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00006708 | S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02043587 | Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00689169 | Targeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01197560 | Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03944772 | Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01450761 | Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00051311 | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT04372927 | ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00136084 | Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04542369 | Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002571 | SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT00912392 | Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00658580 | Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03168594 | Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002740 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02881086 | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT02504359 | Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma | plasma cell leukemia;multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00764907 | Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00006045 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00948090 | PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00453154 | Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03229616 | BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04002947 | Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT05384821 | Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) | Wilms tumor | Etoposide (NPC185498) | NP level |
| NCT00078988 | High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00526396 | STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02782754 | Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT00007852 | Rituximab and Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00028665 | Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03564704 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT03164057 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00002691 | Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01096368 | Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | anaplastic ependymoma | Etoposide (NPC185498) | NP level |
| NCT00005998 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01993810 | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00004031 | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00253435 | N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00613223 | Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas | gliosarcoma | Etoposide (NPC185498) | NP level |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00369317 | Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes | acute basophilic leukemia;acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00003402 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT01481272 | Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002566 | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT03458260 | Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01958372 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | lung adenocarcinoma | Etoposide (NPC185498) | NP level |
| NCT00003650 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00717938 | A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00780104 | Sirolimus in Combination With MEC in High Risk Myeloid Leukemias | chronic myelogenous leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01046825 | Mature B-Cell Lymphoma And Leukemia Study III | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00749723 | Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00003583 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00104676 | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors | teratoma;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT00716066 | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | chronic inflammatory demyelinating polyneuropathy;Myasthenia gravis;neuromyelitis optica;Opsoclonus-Myoclonus Syndrome;Stiff-Person syndrome | Etoposide (NPC185498) | NP level |
| NCT02562365 | Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005022 | Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00025259 | Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00515138 | A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00187161 | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00483561 | Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00726986 | Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02385110 | Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis | leukemia | Etoposide (NPC185498) | NP level |
| NCT05161533 | Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05684991 | Prospective;Multi Centric;Randomized;Double-Blind;Placebo-Controlled Study to Evaluate the Efficacy and Safety of KSM-66 Ashwagandha (Withania Somnifera) in Adults Experiencing High Stress and/or Anxiety | Anxiety|Stress | Withania Somnifera | Plant level As single plant |
| NCT00002598 | Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00186849 | Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00876031 | Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
| NCT02905110 | Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00006258 | Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT04101357 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Etoposide (NPC185498) | NP level |
| NCT00936156 | Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years | primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
| NCT01439568 | A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03293173 | Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03839446 | Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00003967 | Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | fallopian tube cancer;peritoneum cancer;ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00392834 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02633514 | Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma | thymus neoplasm | Etoposide (NPC185498) | NP level |
| NCT01237808 | Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00387868 | Preoperative Treatment of Patients With High Risk Thymoma | Thymoma | Etoposide (NPC185498) | NP level |
| NCT02137928 | Carboplatin Periocular Injection for Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00632827 | Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00450801 | R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04660097 | Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003575 | Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004128 | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002649 | Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | Burkitts lymphoma;diffuse large B-cell lymphoma;follicular lymphoma | Etoposide (NPC185498) | NP level |
| NCT01220297 | Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT | Abnormality of blood and blood-forming tissues | Etoposide (NPC185498) | NP level |
| NCT00004904 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | graft versus host disease;chronic myeloproliferative disorder;leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00002982 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01871766 | Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT02265770 | An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma | childhood ependymoma | Etoposide (NPC185498) | NP level |
| NCT00354107 | Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01390584 | Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00031590 | Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT03437668 | Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia | Schizophrenia | Withania Somnifera | Plant level As single plant |
| NCT03792815 | Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00723658 | S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02987244 | Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00003621 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT04000295 | Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT01864109 | Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma | Ewing sarcoma | Etoposide (NPC185498) | NP level |
| NCT00817752 | Ashwagandha: Effects on Stress;Inflammation and Immune Cell Activation | Inflammation|Cancer|Autoimmune Diseases | Withania Somnifera | Plant level As single plant |
| NCT00002802 | Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00826644 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00812266 | Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00001563 | EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT01457040 | Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00512252 | AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00088530 | BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT04092647 | Ashwagandha for Cognitive Dysfunction | Breast Cancer | Withania Somnifera | Plant level As single plant |
| NCT01458366 | Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00043979 | Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | sarcoma | Etoposide (NPC185498) | NP level |
| NCT02949895 | Study of BMS-986012 in Subjects With Small Cell Lung Caner | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04044222 | A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT02227199 | Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01423747 | Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT05124951 | The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors | central nervous system cancer | Etoposide (NPC185498) | NP level |
| NCT00003541 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02660762 | Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00039130 | Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT03118466 | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00057837 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03781869 | Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00324298 | Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles | testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT03066778 | A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05076786 | Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT03016871 | Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01887340 | Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma | seminoma | Etoposide (NPC185498) | NP level |
| NCT02686346 | Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT04745689 | Study of AZD2811 + Durvalumab in ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01818908 | Trial of DA-EPOCH Regimen for NHL With HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00003421 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002488 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03298074 | Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00006184 | Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00829205 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02819999 | A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00004903 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00968760 | CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT00002514 | Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission | leukemia | Etoposide (NPC185498) | NP level |
| NCT00864318 | Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT00499018 | Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02142049 | Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03992911 | Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002925 | Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002854 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer | cancer | Etoposide (NPC185498) | NP level |
| NCT00004905 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00005964 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00003783,NCT00002598,NCT01154439,NCT00025402,NCT00006045,NCT00002638,NCT00109031,NCT00002768,NCT00002658,NCT00002471,NCT00002701,NCT00005863,NCT00003602,NCT00430118,NCT00534469,NCT00002926,NCT02660762,NCT00100477,NCT00002704,NCT00576979,NCT00002532,NCT00124644,NCT00003243,NCT00005977,NCT00002961,NCT00003727,NCT00005802,NCT00002757,NCT00002945,NCT01900509,NCT00304018,NCT00003728,NCT02356159,NCT00008190,NCT00002788,NCT00004128,NCT00536978,NCT00764907,NCT00002531,NCT00274807,NCT00018954,NCT00002688,NCT00040690,NCT00372593,NCT00350181,NCT00004904,NCT00002719,NCT00002517,NCT00006040,NCT00630565,NCT00400946,NCT00002785,NCT00002865,NCT00458848,NCT00618501,NCT00002868,NCT00002756,NCT00070174,NCT00052299,NCT00427791,NCT00004898,NCT00003436,NCT00410423,NCT00002494,NCT02385110,NCT00005793,NCT00005946,NCT03273829,NCT00002925,NCT00613457,NCT00002816,NCT00002514,NCT00002567,NCT02512926,NCT00002766,NCT00002674,NCT01117441,NCT00004086,NCT00004905,NCT00002912,NCT00003402,NCT00002800,NCT00882076,NCT00002805,NCT00005823,NCT00003816,NCT00002588,NCT00006122,NCT00002549,NCT00039130
|
Burkitt lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KA9 |
NCT00126191,NCT01092182,NCT05270057,NCT00057811,NCT00058461,NCT05389423,NCT00073918,NCT02199184,NCT00002649
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TOP2B
NCT01300793,NCT03206671,NCT02405676,NCT00968760,NCT02443077,NCT00324467,NCT00054665 |
Classical Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30.1 |
NCT03077828,NCT00025259,NCT05008224,NCT02661503,NCT04044222,NCT02166463,NCT00967369,NCT02243436
|
Primary haemophagocytic lymphohistiocytosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.23 |
NCT04077905,NCT02631109,NCT01104025,NCT02912702,NCT03742115,NCT00426101,NCT01818908,NCT04551131
|
Primary neoplasms of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
NCT00003935,NCT02905110,NCT00027846,NCT00003625,NCT00078988,NCT00003573,NCT00003141,NCT00085098
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT05142865,NCT05076786,NCT00193531,NCT00094497,NCT03992911,NCT00001339,NCT00003558,NCT03168594
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
NCT00689195
NCT01258634,NCT00504140,NCT04154189,NCT00134030,NCT00180908,NCT00023998 |
Peripheral T-cell lymphoma, not otherwise specifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.C |
NCT05458180,NCT03321890,NCT00970385,NCT03586999,NCT00632827,NCT00791947,NCT04061772
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2B
NCT02592876,NCT03019640,NCT00002649,NCT00086944,NCT00073918 |
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00310128,NCT00002524,NCT00049036,NCT00001563,NCT00002571,NCT01775475
|
GerminomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1E13 |
NCT00002596,NCT02782754,NCT00864318,NCT02582697,NCT01873326,NCT00274950
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
TOP2B
NCT00045617,NCT00003053,NCT00589056,NCT00869752,NCT03432598,NCT00005022,NCT00003606,NCT00011921,NCT00144989,NCT00003158,NCT00066222,NCT00807755,NCT00003696,NCT00061919,NCT00616785,NCT00003284,NCT00387699,NCT00045162,NCT00002642,NCT00003812,NCT00006374,NCT00003860,NCT00041015,NCT00025272,NCT00021112,NCT00002887,NCT00006487,NCT00002823,NCT00004186,NCT03567642,NCT00632853,NCT00003299,NCT00002858,NCT00621361,NCT01134861,NCT00003364,NCT00072527,NCT01579929,NCT00083161,NCT00062439,NCT00002550,NCT00004176,NCT00049218,NCT00033696,NCT00984997,NCT00003583,NCT00660504,NCT00554463,NCT03811002,NCT00726986,NCT00002822,NCT00041054,NCT00006012 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
TOP2B
NCT00186966,NCT02349178,NCT03182244,NCT02638428,NCT02400281,NCT00315705,NCT00660036,NCT03504410,NCT00880243,NCT03926624,NCT00780104,NCT02626338,NCT03591510,NCT01411267,NCT00002798,NCT02632708,NCT00774046,NCT04293562,NCT03839446,NCT03793478,NCT00003190,NCT03860844,NCT00003190,NCT03164057,NCT00079482,NCT01729845,NCT01237808,NCT00906945,NCT02773732,NCT01830777,NCT01677949,NCT04326439,NCT00006363,NCT02306291,NCT00151242,NCT02039726,NCT01180322,NCT00146120,NCT02848183,NCT03118466,NCT01025778,NCT00939653,NCT02070458,NCT01027923,NCT00151255,NCT02421939,NCT03568994,NCT00136084,NCT00703820,NCT01681537,NCT02631252,NCT00369317,NCT00512252 |
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TOP2B
NCT03293173,NCT03019640,NCT01092182,NCT05389423,NCT02471911,NCT02329080,NCT04139304,NCT03349346,NCT02412267,NCT02219737,NCT04833114,NCT00529503,NCT03064867,NCT05466318,NCT00057811,NCT00073918,NCT01481272,NCT01914718,NCT02592876,NCT00058461,NCT01226849,NCT01415765,NCT00591630,NCT00137995,NCT03383406,NCT02366663,NCT01555541,NCT01181271,NCT02570542,NCT04002947,NCT00689169,NCT02142049,NCT03367143,NCT00556127,NCT03018626,NCT03229616,NCT05221645,NCT00499018,NCT01030900,NCT00002649,NCT01197560,NCT03213977,NCT01959698,NCT00086944,NCT02228512,NCT01165112,NCT03072771,NCT05348213,NCT05364424,NCT00482053,NCT00776802,NCT02636322,NCT03736616 |
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT00073918,NCT00310128,NCT01979536,NCT00354107,NCT00057811
|
Neuroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH85Z0 |
NCT00025623,NCT00003119,NCT00017225,NCT00793845,NCT05338541,NCT00416676,NCT00017368,NCT02176967,NCT00003141,NCT02605421,NCT00798148,NCT00025649,NCT00040872,NCT01704716,NCT00808899,NCT00025610,NCT01059071,NCT00578864,NCT00002634,NCT00024193,NCT00539500,NCT00004110,NCT02771743,NCT00499616,NCT01857934,NCT00135135,NCT03061656,NCT00004188,NCT00276731,NCT00003093,NCT00025597,NCT00002740,NCT00025428,NCT00253435,NCT00005978,NCT04221035,NCT00070200,NCT00002802,NCT03786783,NCT00567567,NCT00186849,NCT00365755,NCT00030719
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT02349178,NCT00131027,NCT02553460,NCT03117751,NCT02003222,NCT03643276,NCT05192889,NCT00098839,NCT03020030,NCT02776605,NCT02199184,NCT01411267,NCT01949129,NCT02881086,NCT00022737,NCT03860844,NCT01025778,NCT01331590,NCT00187083,NCT02101853,NCT01677949,NCT02883049,NCT03553238,NCT01423500,NCT00315705,NCT00549848,NCT05453500,NCT00187161,NCT00476190,NCT03991884,NCT00720109,NCT00187005,NCT02518750,NCT00137111,NCT00057811,NCT00186875,NCT01457040,NCT02043587,NCT01423747,NCT03023046
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TOP2B
NCT00051311,NCT04177004,NCT03531281 |
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00025103,NCT00002611,NCT00002610,NCT00047138
|
Acute erythroid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.35 |
NCT00002798,NCT00006363,NCT00003190,NCT00369317
|
Acute monocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9NE2 |
NCT00003190,NCT00369317,NCT00002798,NCT00006363
|
Acute myelomonocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH78Y4 |
NCT00369317,NCT00006363,NCT00003190,NCT00002798
|
Acute megakaryoblastic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.36 |
NCT00369317,NCT00003190,NCT00002798,NCT00006363
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT02768558,NCT01076231,NCT00924209,NCT04372927,NCT02947113,NCT01733589,NCT00985855,NCT00216125,NCT01993810,NCT00417248,NCT05298423,NCT00240097,NCT01411098,NCT00776698,NCT01222572,NCT02733107,NCT04989283,NCT01565772,NCT03944772,NCT02987998,NCT00682383,NCT02262325,NCT03840902,NCT00686959,NCT03663166,NCT04203511,NCT02940990,NCT01822496,NCT00191139,NCT04092283,NCT04380636,NCT03519971
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT01840566,NCT03794167,NCT03792815,NCT01097057,NCT00367497,NCT00691210,NCT00712582,NCT00193505,NCT01900509,NCT01178658,NCT03161054,NCT00088530,NCT02371161,NCT02987244,NCT02836639,NCT02356159,NCT00481832,NCT00262210,NCT03623087,NCT00250718,NCT01746173,NCT02408042,NCT01300793,NCT00100477,NCT01178645,NCT00324467,NCT00504751,NCT00350181,NCT02703272,NCT01458366,NCT00809341,NCT03458260
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
NCT00225173,NCT02686346,NCT00667615,NCT01468740,NCT01356680,NCT03016871,NCT03755804,NCT04638790,NCT03407144,NCT04981899,NCT01030900,NCT00388349,NCT02298283,NCT01169636,NCT01181271,NCT02408042,NCT00439361,NCT00026208,NCT01900509,NCT01569204,NCT01165112,NCT01251107,NCT00691210,NCT01476839,NCT03517137,NCT00352027,NCT01920932,NCT04871607,NCT02227199,NCT03418038,NCT02356159
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT02504359,NCT00871013,NCT00003401,NCT00083915,NCT00083538,NCT00572169,NCT00002657,NCT03385096,NCT01653418,NCT01548573,NCT00004903,NCT00002552,NCT05294055,NCT00004904,NCT00734877,NCT00869232,NCT02356159,NCT00083681,NCT00005834,NCT00006184,NCT01055301,NCT03570983,NCT00349778,NCT00005987,NCT00574080,NCT00003399,NCT00304018,NCT00083551,NCT00005946,NCT03004287
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT00761761,NCT00761761,NCT00761761
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
TOP2B
NCT03100955,NCT03769935 |
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
CASP3,TOP2B
NCT01014767 |
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associatedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.5 |
NCT02538926,NCT03007147,NCT01000285
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT00042835,NCT01958372,NCT00020709
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT00276809,NCT00275015,NCT01181271
|
CNS embryonal tumour, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8SH6 |
NCT00336024,NCT00936156,NCT00006461
|
GliosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9RC8 |
NCT00613223,NCT00612430,NCT02502708
|
Rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GA1 |
NCT00025363,NCT00162695,NCT01871766
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT00020709,NCT01947062,NCT00042835
|
Seminoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH9FM4 |
NCT01887340,NCT02341989,NCT03937843
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
NCT00005863,NCT00006040,NCT00005823
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NCOA3,TOP2B
NCT00053352 |
Adrenal cortical carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KH2 |
NCT03723941,NCT00304070,NCT03583710
|
Ewing sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B52 |
NCT02063022,NCT01864109,NCT00568464
|
Extranodal NK/T-cell lymphoma, nasal typeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.6 |
NCT04917250,NCT02631239,NCT02825147
|
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
NCT01710176,NCT00876031,NCT02784015
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
NCT02338518,NCT02949258 |
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
CASP3,NCOA3,TOP2B
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
NCT00354744,NCT01294670,NCT00003141,NCT00003052,NCT00077285,NCT00020566,NCT00470223,NCT00334867,NCT00061893,NCT00072280,NCT00006734,NCT00043979,NCT00002974,NCT00002516,NCT00014313,NCT00002936,NCT00204646,NCT00379457,NCT00742924,NCT00003937
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT03437668,NCT01793935
|
Stress, not elsewhere classifiedDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QE01 |
NCT05684991,NCT05430685
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2B
NCT00000660 |
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
TOP2B
NCT01528969 |
Chronic myeloid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4XG8 |
NCT00780104,NCT03747679
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04573153,NCT04356690
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NCOA3
NCT03017326 |
Acute basophilic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.37 |
NCT00369317,NCT00006363
|
Choroid plexus tumoursDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.22 |
NCT00500890,NCT01014767
|
Castlemans diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B2Y |
NCT02228512,NCT04585893
|
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT00350181,NCT00004904
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
NCT00003967,NCT00003380
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00003380,NCT00003967
|
Nephroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5QN3 |
NCT05384821,NCT00379340
|
Lymphoid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7Q12 |
NCT02523976,NCT03328104
|
Refractory anaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A30 |
NCT00209833,NCT00002798
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT02372409,NCT04765098
|
GanglioneuroblastomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH77W7 |
NCT02176967,NCT03786783
|
Other specified gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0Y |
NCT01032070,NCT02265770
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00004904,NCT00003816
|
Teratoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G5 |
NCT00104676,NCT00053352
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
NCT00003816,NCT00006363,NCT00002517,NCT02356159,NCT03164057,NCT00003436,NCT00304018,NCT00002800,NCT00774046,NCT00005863,NCT01729845,NCT00002926,NCT00006040,NCT00003243,NCT00369317,NCT00005823,NCT00004904,NCT00005946,NCT00003602
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
TOP2B
NCT04092647 NCT00810017,NCT03535961,NCT00002836,NCT04452370,NCT00006032,NCT00004900,NCT00006260,NCT00693719,NCT00020722,NCT03923179,NCT00002509,NCT00004906,NCT01589159,NCT00012311,NCT01492556 |
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT04047862,NCT00009815,NCT02794571,NCT02157792,NCT00653068,NCT00811993,NCT02964013,NCT03617432,NCT00027898,NCT04469530,NCT00573690,NCT00003194,NCT00878449,NCT03628131,NCT00193596,NCT00551005,NCT00006047
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
TOP2B
NCT00039130,NCT00416832,NCT00002757,NCT00003957,NCT00041327,NCT00450801,NCT00098774,NCT00242996,NCT00049439,NCT00004169,NCT00005998,NCT00003243,NCT00005964,NCT00060385,NCT00577629,NCT00002941,NCT00003114,NCT00002691,NCT00002936,NCT05006664,NCT00079105,NCT00002987,NCT00002714,NCT00255723,NCT00002827,NCT00002494,NCT00018954,NCT01329900,NCT00002766,NCT00005090,NCT00003632,NCT00933673,NCT00003215,NCT00822120,NCT00004898,NCT00004086,NCT00006669,NCT00005985,NCT00006373,NCT03188198,NCT00398554,NCT02436707,NCT00265031,NCT00058292,NCT00264953,NCT00005977,NCT00499343,NCT00695409,NCT00723658,NCT00666484,NCT00002982,NCT00003262,NCT00598169,NCT00003578,NCT00005589,NCT00005631,NCT00069238,NCT00217503,NCT00003631,NCT00002510,NCT00117598,NCT00515138,NCT00641381,NCT00002481,NCT00003389,NCT00002522,NCT00025636,NCT00002590,NCT00070187,NCT00521014,NCT00016887,NCT00003402,NCT00025064,NCT01511562,NCT00002829,NCT05367856,NCT00049595,NCT00392834,NCT00002521,NCT02359162,NCT00002488,NCT00439556,NCT00002461,NCT00577993,NCT00007852,NCT00006708,NCT00032149,NCT01063439,NCT00028665,NCT00829205,NCT00908180,NCT00562978,NCT01516567,NCT00005613,NCT00003397,NCT00003423,NCT00005578,NCT00012051,NCT00032019,NCT00002697,NCT00002905,NCT01046825,NCT00003421,NCT00732498,NCT00983944,NCT00003815,NCT00274924,NCT01390584,NCT00003816,NCT00039195,NCT00002715,NCT00801918,NCT00559104,NCT00002557,NCT00569985,NCT00003728,NCT00233987,NCT00109928,NCT00536978,NCT00002565,NCT00003575,NCT00052923,NCT00004031,NCT00720447,NCT00003113,NCT00006695,NCT00003541,NCT00004907,NCT00568607,NCT00345865,NCT00002471,NCT00004010,NCT00472056,NCT00080886,NCT00002835,NCT00041210,NCT00678327,NCT00003650,NCT00040690,NCT00020943,NCT00005867,NCT00053768,NCT00265889,NCT00007865,NCT00118209,NCT00920153,NCT00006455,NCT00948090,NCT00109031,NCT00244946 |
RetinoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D02.2 |
NCT01783535,NCT02870907,NCT01906814,NCT00072384,NCT00004006,NCT04681417,NCT00179920,NCT00554788,NCT02137928,NCT00110110,NCT00002675,NCT01899066,NCT00335738,NCT00186888,NCT02116959
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT00003621,NCT00392886,NCT00047281,NCT00003309,NCT00006258,NCT00003859,NCT00278252,NCT00278278,NCT00002876,NCT05124951,NCT00025324,NCT00004224,NCT00084838,NCT00003996
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT00057837,NCT02179528,NCT02949895,NCT00702962,NCT01064466,NCT02499770,NCT02815592,NCT02194049,NCT02580994,NCT00363415,NCT00958022,NCT04878016,NCT00537511,NCT04728230,NCT00791154,NCT04624204,NCT02738346,NCT04422210,NCT03116971,NCT01859741,NCT04012606,NCT02763579,NCT04996771,NCT00658580,NCT04189094,NCT04712903,NCT05092412,NCT04346914,NCT05484583,NCT00544596,NCT04684017,NCT00388960,NCT05001412,NCT04774380,NCT05468489,NCT01555710,NCT03781869,NCT00143455,NCT01573338,NCT01237678,NCT04543890,NCT00812266,NCT05142696,NCT01439568,NCT05353257,NCT03382561,NCT04028050,NCT00066742,NCT00526396,NCT02289690,NCT03135977,NCT04924101,NCT02899728,NCT04005716,NCT04683198,NCT04560972,NCT04696939,NCT05026593,NCT00927875,NCT04702880,NCT05116007,NCT02934503,NCT05091567,NCT00916669,NCT01722292,NCT05354700,NCT05224141,NCT00977561,NCT01563601,NCT00043927,NCT04490421,NCT00079040,NCT04696575,NCT02722369,NCT04951115,NCT02819999,NCT04363255,NCT00320359,NCT00912392,NCT04675697,NCT03700359,NCT03059667,NCT02402920,NCT00401609,NCT01450761,NCT04101357,NCT03467360,NCT00717938,NCT00017251,NCT02875457,NCT04730999,NCT02323737,NCT03711305,NCT04622228,NCT03699956,NCT03041311,NCT00613626,NCT04660097,NCT04699838,NCT04665856,NCT00926640,NCT04740021,NCT00042978,NCT04542369,NCT00826644,NCT01987232,NCT04923776,NCT03389087,NCT00453154,NCT04234607,NCT05403723,NCT00168896,NCT03850067,NCT05161533,NCT05361395,NCT00887159,NCT02748889,NCT04254471,NCT00682981,NCT05245994,NCT03066778,NCT03613597,NCT04063163,NCT04745689,NCT04472949,NCT02337712,NCT05384015,NCT03043872,NCT05309629,NCT04256421
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TOP2B
NCT04000295,NCT00005612,NCT04520074,NCT00274950,NCT00053352,NCT00003380,NCT02867956,NCT02562365,NCT03901118,NCT00003967,NCT03298074,NCT05422183 |
Precursor B-lymphoblastic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A70 |
NCT02881086,NCT02845882,NCT00195871,NCT00073918,NCT03564704,NCT02043587,NCT00058461,NCT03328104,NCT03991884,NCT01451515,NCT03023046
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00817752
NCT02018861,NCT01604863,NCT00002854,NCT02937116,NCT00109031,NCT04778410,NCT00881166,NCT00003597,NCT02574728 |
Mantle cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.5 |
NCT00878254,NCT00571493,NCT02896582,NCT00114738,NCT00073918,NCT00209222,NCT00086944,NCT00005780,NCT01181271,NCT03019640
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
NCT00104676,NCT00231582,NCT00936936,NCT03937843,NCT02341989,NCT00002566,NCT00003941,NCT00324298,NCT00053352,NCT00002596
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT00514540,NCT00151060,NCT00973882,NCT00028769,NCT00483561,NCT00003084,NCT00004054,NCT00176605,NCT02861573,NCT00627354
|
Medulloblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8P29 |
NCT01857453,NCT00006461,NCT02502708,NCT00180791,NCT00031590,NCT00749723,NCT04501718,NCT01356290,NCT02025881,NCT00336024
|
Autoimmune diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40-4A45 |
NCT00817752
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00817752
|
Other specified periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C.Y |
NCT03533972
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
NCT05684991
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT01793935
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
NCT03780621
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TOP2B
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
TOP2B
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2B
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TOP2B
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2B
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2B
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
TOP2B
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2B
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
TOP2B
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2B
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2B
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
TOP2B
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
TOP2B
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
TOP2B
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
TOP2B
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TOP2B
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2B
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
TOP2B
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2B
|
Mature B-cell neoplasms, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A8Z |
NCT02911142
|
Neuromyelitis opticaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A43 |
NCT00716066
|
Embryonal carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8MB9 |
NCT00053352
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT02502708
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01756989
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01435018
|
Other specified malignant neoplasms of the ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.Y |
NCT02429700
|
Inappropriate saccadesDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C85.02 |
NCT00716066
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT02199184
|
Astrocytoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH96C7 |
NCT02372409
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT03636971
|
NeutropeniaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B00 |
NCT00002800
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT00351195
|
Oligodendroglioma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7W59 |
NCT02372409
|
Myeloproliferative and myelodysplastic disease, unclassifiableDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A44 |
NCT00003243
|
Ependymoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH6922 |
NCT01096368
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
NCT00002798
|
Malignant trophoblastic neoplasms of placentaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C75.0 |
NCT02639650
|
Oligodendroglioma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH8844 |
NCT00303849
|
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.1 |
NCT00073918
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT02633514
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT00288626
|
Diseases of the blood or blood-forming organs, unspecifiedDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT01220297
|
Malignant neoplasms of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A |
NCT01525927
|
Refractory anaemia with excess of blastsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A35 |
NCT00002798
|
Chronic inflammatory demyelinating polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C01.3 |
NCT00716066
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT03669783
|
Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cordDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E4A.0 |
NCT00716066
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
NCT04330326
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT00202800
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
NCT00716066
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
NCT05450458
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT01013779
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
NCT02504359
|
Hereditary sensory or autonomic neuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C21.Z |
NCT04762758
|
Pilocytic astrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH12D2 |
NCT02372409
|
Embryonal rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G1 |
NCT01055314
|
ThymomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT00387868
|
Tumours of neuroepithelial tissue of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.2 |
NCT02653196
|
Waldenstrom macroglobulinemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH8GW4 |
NCT00073918
|
Malignant neoplasm metastasis in mediastinumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D71 |
NCT00003941
|
T lymphoblastic leukaemia/lymphomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH50W7 |
NCT02538926
|
ConstipationDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.0 |
NCT01474499
|
Adult T-cell leukaemia/lymphoma (HTLV-1 positive)Disease Category: X.Extension CodesDisease ICD-11 Code: XH6TE2 |
NCT00145002
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
NCT00374881
|
Myeloid sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.39 |
NCT01371981
|
OligoastrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH6F49 |
NCT02372409
|
Alveolar rhabdomyosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7099 |
NCT01055314
|
Small cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0YB0 |
NCT05058651
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
NCT04322318
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT02595424
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
NCT03980925
|
Optic nerve disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40 |
NCT02372409
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
CASP3
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CASP3
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CASP3
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CASP3
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CASP3
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
Plant-Targeted Human Disease Network
>> Targets derived from weak experimental activities
